CraniUS
A manufacturer of medical equipment.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| N/A | €0.0 | round | |
* | $1.0m | Grant | |
| Total Funding | 000k | ||
Related Content
CraniUS LLC is a pioneering startup based in Baltimore, MD, founded in May 2021 by Dr. Chad Gordon. The company operates in the medical technology (MedTech) sector, focusing on innovative solutions for chronic brain diseases. CraniUS is developing the NeuroPASS device, the first smart, refillable, and fully implantable medical device designed for direct medicine delivery to the brain. This device aims to bypass the blood-brain barrier—a protective shield around the brain that prevents many medications from entering—allowing for more effective and long-term treatment of brain conditions.
The NeuroPASS device is powered by a novel wireless charging system, making it convenient and user-friendly for patients. Currently, the device is in the pre-clinical development stage, meaning it is being tested in labs but is not yet available for commercial use. The company is on the pathway to clinical studies, which are necessary steps before the device can be approved for widespread medical use.
CraniUS primarily serves patients with chronic brain diseases, a market that includes conditions such as Alzheimer's, Parkinson's, and brain tumors. These diseases often require long-term medication management, making the NeuroPASS device a potentially transformative solution. The company’s business model revolves around research and development (R&D), aiming to bring groundbreaking diagnostics and treatments to market. Once the NeuroPASS device is commercially available, CraniUS will generate revenue through the sale of the device and possibly through partnerships with healthcare providers and pharmaceutical companies.
In summary, CraniUS is a MedTech startup focused on developing a revolutionary medical device for direct brain medicine delivery, targeting chronic brain disease patients. The company is still in the R&D phase but has already garnered significant recognition, being named the Top MedTech Startup of 2023 by MedTech Outlook.
Keywords: MedTech, brain diseases, NeuroPASS, implantable device, wireless charging, chronic conditions, R&D, innovation, diagnostics, treatments.